chr16-75540017-A-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000258173.11(TMEM231):āc.928T>Gā(p.Leu310Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00219 in 1,612,450 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. L310L) has been classified as Likely benign.
Frequency
Consequence
ENST00000258173.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM231 | NM_001077418.3 | c.928T>G | p.Leu310Val | missense_variant | 7/7 | ENST00000258173.11 | NP_001070886.1 | |
TMEM231 | NM_001077416.2 | c.1087T>G | p.Leu363Val | missense_variant | 6/6 | NP_001070884.2 | ||
TMEM231 | NR_074083.2 | n.1094T>G | non_coding_transcript_exon_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM231 | ENST00000258173.11 | c.928T>G | p.Leu310Val | missense_variant | 7/7 | 1 | NM_001077418.3 | ENSP00000258173.5 | ||
TMEM231 | ENST00000568377.5 | c.1015T>G | p.Leu339Val | missense_variant | 6/6 | 1 | ENSP00000476267.1 | |||
TMEM231 | ENST00000565067.5 | c.784T>G | p.Leu262Val | missense_variant | 6/6 | 5 | ENSP00000457254.1 | |||
TMEM231 | ENST00000562410.5 | n.*730T>G | non_coding_transcript_exon_variant | 7/7 | 1 | ENSP00000454582.1 | ||||
TMEM231 | ENST00000570006.5 | n.*308T>G | non_coding_transcript_exon_variant | 7/7 | 5 | ENSP00000455520.1 | ||||
TMEM231 | ENST00000562410.5 | n.*730T>G | 3_prime_UTR_variant | 7/7 | 1 | ENSP00000454582.1 | ||||
TMEM231 | ENST00000570006.5 | n.*308T>G | 3_prime_UTR_variant | 7/7 | 5 | ENSP00000455520.1 | ||||
ENSG00000260092 | ENST00000460606.1 | n.157+2585T>G | intron_variant | 1 | ENSP00000457544.1 |
Frequencies
GnomAD3 genomes AF: 0.00176 AC: 267AN: 151980Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.00171 AC: 423AN: 247936Hom.: 3 AF XY: 0.00163 AC XY: 219AN XY: 134502
GnomAD4 exome AF: 0.00224 AC: 3271AN: 1460352Hom.: 10 Cov.: 31 AF XY: 0.00215 AC XY: 1559AN XY: 726414
GnomAD4 genome AF: 0.00176 AC: 267AN: 152098Hom.: 2 Cov.: 32 AF XY: 0.00167 AC XY: 124AN XY: 74386
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 03, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | TMEM231: BP4, BS2 - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Joubert syndrome 20;C3809352:Meckel syndrome, type 11 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 08, 2022 | - - |
TMEM231-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 31, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at